| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HED.21848 |
| P698 | PubMed publication ID | 21953802 |
| P2093 | author name string | Liying Zhang | |
| James Wright | |||
| Stephen M Sagar | |||
| Ian Poon | |||
| Fazilat F Mohammed | |||
| Ian D Hodson | |||
| Liz Elliott | |||
| P2860 | cites work | A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9 | Q56532851 |
| The Need for Adverse Effects Reporting Standards in Oncology Clinical Trials | Q57618434 | ||
| A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma | Q58876866 | ||
| Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx | Q71301621 | ||
| Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer | Q72880125 | ||
| Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma | Q73280172 | ||
| Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial | Q73370356 | ||
| Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial | Q73589822 | ||
| Acute phase response during radiotherapy | Q73590020 | ||
| Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma | Q74561303 | ||
| Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment | Q74569553 | ||
| Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer | Q74668378 | ||
| Levels of some acute-phase proteins in the serum of patients with cancer during radiotherapy | Q79102358 | ||
| Acute-phase proteins and other systemic responses to inflammation | Q28296941 | ||
| Toxicity in head and neck cancer: a review of trends and issues | Q33887361 | ||
| Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis | Q34278528 | ||
| Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review | Q35125688 | ||
| Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis | Q35597437 | ||
| Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer | Q36048061 | ||
| Assessing the reliability of two toxicity scales: implications for interpreting toxicity data. | Q36763990 | ||
| Potential clinical applications of C-reactive protein | Q37815158 | ||
| Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study | Q39977232 | ||
| TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group | Q40207325 | ||
| Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity | Q40910617 | ||
| An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer | Q41939496 | ||
| The erythrocyte sedimentation rate. Still a helpful test when used judiciously | Q44066605 | ||
| Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer | Q44076023 | ||
| Acute phase protein response to tissue injury. | Q44272008 | ||
| Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer | Q44674194 | ||
| Combined bleomycin and radiotherapy in oral cancer | Q45272221 | ||
| Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma | Q46700424 | ||
| C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancer | Q48016794 | ||
| The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questio | Q51947206 | ||
| P433 | issue | 7 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 985-993 | |
| P577 | publication date | 2011-09-26 | |
| P1433 | published in | Head & Neck | Q13703062 |
| P1476 | title | Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer. | |
| P478 | volume | 34 |
| Q54231122 | Acute oral mucositis in nasopharyngeal carcinoma patients treated with radiotherapy: association with genetic polymorphism in DNA DSB repair genes. |
| Q89496335 | Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population |
| Q39379337 | Biomarkers in the assessment of oral mucositis in head and neck cancer patients: a systematic review and meta-analysis. |
| Q50533722 | Effect of surgery and radiotherapy on complete blood count, lymphocyte subsets and inflammatory response in patients with advanced oral cancer |
| Q34970929 | Inflammatory biomarker C-reactive protein and radiotherapy-induced early adverse skin reactions in patients with breast cancer. |
| Q38096877 | Inflammatory markers in patients after hematopoietic stem cell transplantation |
| Q39335124 | Oral shedding of human herpesviruses in patients undergoing radiotherapy/chemotherapy treatment for head and neck squamous cell carcinoma. |
| Q57154425 | Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling |
| Q49557087 | Prediction of acute gastrointestinal and genitourinary radiation toxicity in prostate cancer patients using lymphocyte microRNA. |
| Q92354772 | The development of a nomogram to predict post-radiation necrosis in nasopharyngeal carcinoma patients: a large-scale cohort study |
| Q36006051 | Ultrasensitive microfluidic array for serum pro-inflammatory cytokines and C-reactive protein to assess oral mucositis risk in cancer patients |
Search more.